News

Moderna Stock Is Climbing on Trial Data. A Flu-Covid Vaccine Isn’t a Sure Thing.
An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine
RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...
Stock Movers: Circle Falls, Disney Climbs, Moderna Meets Flu Shot Goal
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
GlobalData on MSN20h
Moderna’s mRNA flu shot outperforms current standard at Phase III
The trial readout comes at a time of turbulence in the vaccine sector after RFK Jr replaced every member of the ACIP panel.
NBC New York1d
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
Moderna on Monday said its experimental mRNA-based flu vaccine produced a stronger immune response than a currently available shot in a late-stage trial, clearing a path forward for the product ...
STAT23h
Pharmalittle: We’re reading about a Moderna flu vaccine, a J&J loss over 340B rebate plans, and more
Moderna disclosed that a study of 56,000 volunteers older than 50 found its new mRNA flu vaccine was more effective than an ...